Piscataway, NJ, October 10, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Ketorolac Tromethamine Injection, USP to its product line.
Ketorolac Tromethamine Injection, USP is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level.
Ketorolac Tromethamine Injection, USP is available in:
- 15 mg/ mL | 10 x 1 mL Single- Dose Vials
- 15 mg/ mL | 25 x 1 mL Single- Dose Vials
- 30 mg/ mL | 25 x 1 mL Single- Dose Vials
- 60 mg/ mL | 25 x 2 mL Single- Dose Vials
To learn more about Ketorolac Tromethamine Injection, USP, please visit https://www.camberpharma.com/ketorolacinjection
